Drug Indications Flashcards
ACE-Inhibitors
LV systolic dysfunction, HTN, afterload reduction in diastolic HF, status post STEMI or status post NSTEMI in pts with LV systolic dysfunction
ARBs
same as for ACE-inhibitor
LV systolic dysfunction, HTN, afterload reduction in diastolic HF, status post STEMI or status post NSTEMI in pts with LV systolic dysfunction
aspirin
primary prevention of CAD in high risk pt (ASCVD >10%), secondary prevention in all pts. If stent. ASA 325 mg/d for Afib pts with low risk of thromboembolus
beta blocker
angina, STEMI, NSTEMI, SVT, HTN, rate control in Afib, can be helpful for hypertrophic cardiomyopathy, VT
CCB
angina. avoid in LV systolic dysfunction. rate control Afib, verapamil can be helpul for hypertrophic cardiomyopathy
clopidogrel
s/p STEMI, s/p NSTEMI. bare metal stent (one month) or drug eluting stent (1 year at least, ideally indefinitely).
digoxin
rate control in Afib, rate control for SVT (less good of choice than Bblocker or CCB but can be used), pos inotropy in heart failure, narrow therapeutic window
heparin/LMWH
ACS. bridge to warfarin. DVT, PE
statin
HLD, all pts with NSTEMI/STEMI, unstable angina, chronic angina
warfarin
afib, mechanical valves, left ventricular thrombus (v big MI), after acute DVT/PE for 3-6 months